Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
Open | $2.550 |
Close | $2.610 |
Volume / Avg. | 275.546K / 1.429M |
Day Range | 2.500 - 2.820 |
52 Wk Range | 2.350 - 44.800 |
Market Cap | $4.101M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 4.31% |
Days to Cover | 1.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bio-Path Hldgs (NASDAQ: BPTH) through any online brokerage.
Other companies in Bio-Path Hldgs’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
The latest price target for Bio-Path Hldgs (NASDAQ: BPTH) was reported by Roth MKM on Thursday, April 18, 2024. The analyst firm set a price target for 40.00 expecting BPTH to rise to within 12 months (a possible 1426.72% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $2.62 last updated Today at May 3, 2024 at 6:14 PM EDT.
There are no upcoming dividends for Bio-Path Hldgs.
Bio-Path Hldgs’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Bio-Path Hldgs.
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.